Regenerative Therapeutics
Advancing cell therapy from bench to bedside
FDA-licensed cord blood-derived cell therapies. An active clinical pipeline. 27 years of stem cell science translated into patient outcomes.
FDA
FDA Biologics License
US License 2280 · Approved 2024
2,300+ transplants
Across 325+ institutions
Biologics Programs
FDA US License 2280 RMAT Designation FACT Accredited AABB Accredited 325+ Institutions
Medical information inquiries
Product information, clinical data requests, and medical affairs inquiries.
Contact Medical Affairs